Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Arthritis, Rheumatoid × 9-(4-fluoro-3-hydroxymethylbutyl)guanine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Multiple Myeloma 1 Glioma 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1 Arthritis, Rheumatoid 1

Interventions

Nivolumab 2 Specimen Handling 1 Rituximab 1 9-(4-fluoro-3-hydroxymethylbutyl)guanine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00185848 2017-03-14

Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis

Stanford University

Phase 1 Completed

Arthritis, Rheumatoid, Brain Neoplasms, Glioma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡